Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Treating depression with ketamine: We need incremental treatment for depression

Shaili Jain, MD
Meds
March 25, 2019
Share
Tweet
Share

Recently, the Food and Drug Administration approved a nasal spray version of the drug Ketamine, named Spravato (esketamine), for use as a supplement to oral antidepressants taken by adults living with treatment-resistant depression.

The announcement was accompanied by a flurry of media excitement as Spravato is the first medication for depression with a new mechanism of action since Prozac (fluoxetine hydrochloride) was approved in the late 1980s.

The risks of Esketamine are far from insignificant and include sedation, disassociation, misuse, and abuse.  For these reasons the spray will be available through a restricted distribution system and comes with a black box warning.

Nonetheless, its approval has been eagerly embraced as a powerful new tool to fight intractable depression with emphasis being placed on it’s silver bullet potential to rapidly relieve the symptoms of chronic, debilitating depression.

The powerful allure of silver bullets and heroic care

Watching the news coverage of this announcement, along with powerful patient testimonials of life-altering transformations, I felt an uneasy sense of déjà vu.  The familiar sense of how a tsunami of zeal gathers to embrace silver bullets.

This déjà vu comes from my experiences as a frontline clinician who has worked through many cycles of medication launches. Launches which stimulated hope on a mass scale only to over promise, under deliver and sometimes end in tragedy.

Oxycontin and Ambien and more recently the commonly prescribed class of anti-anxiety medications called benzodiazepines (think Valium, Xanax etc.) are just some such examples.

The cadence of these stories has striking similarities.

A medication is pushed onto the market with much fanfare (and marketing dollars from Big Pharma), and stories rapidly spread that it is a magic bullet, a panacea for the most stubborn symptoms. It quickly becomes the medication du jour.

Doctors don’t want to be accused of not being able to keep up with the latest and greatest discoveries and are eager to provide heroic relief to their patients who are suffering. Pressure builds to prescribe from patients (who are exposed to direct to consumer marketing), professional societies (whose guidelines and policies are heavily influenced by opinion leaders who often have a financial connection to the medication in question) and even hospital groups and medical regulatory agencies.

Soon begins a journey down a slippery slope.  The medication starts to be prescribed at higher than recommended doses and for medical conditions for which they do not have an FDA indication and for longer than they were supposed to be. The medication becomes over-prescribed by doctors and abused by patients. Doctors who are not specialists, in that field, start to prescribe, professional guidelines get diluted, oversight and caution are thrown to the wind.

Eventually, population health data becomes available which offers a bird’s eye view of such prescribing patterns, and their full side effect profile becomes apparent.

ADVERTISEMENT

In the future, this cycle can be broken if the tsunami of zeal behind heroic care does not drown the equally important provision of incremental care.

The invisible nature of incremental care

The act of writing a prescription is easy, but the job of providing the steady, intimate incremental treatment that really helps patients over the weeks, months and years that follow is much harder and too often gets pushed to the side.

Incremental care involves: taking the time to build a therapeutic alliance with your patient; being thorough in your diagnostic evaluation; fighting for organizational scaffolding to support your practice; ongoing communication with your patients loved ones and the other doctors involved in their care; continually educating your patient about the vital importance of sleep wellness, healthy nutrition, regular exercise and other lifestyle factors that negatively impact their mental health and an eternal watchfulness for side effects, lapses in treatment adherence and if your patient is taking medications or other substances that could have negative interactions with prescription medications.

Providing incremental care means: having a healthy skepticism about pills that are touted as miracles for complex health conditions; remembering that with new medications it takes time for the full array of side effects to emerge; only trying newer medications when tried and tested options have failed and tapering patients off medications when they no longer need them.

The hope is that Spravato (esketamine) will improve the lives of millions of adults living with treatment-resistant depression.  But let’s not forget the incremental care that will be vital to turning that hope into a reality.

Shaili Jain is a psychiatrist and can be reached at her self-titled site, Shaili Jain, MD, and on Twitter @shailijainmd. She blogs at The Aftermath of Trauma on Psychology Today, where this article originally appeared on March 19th, 2019..

The views expressed are those of the author and do not necessarily reflect the official policy or position of the Department of Veterans Affairs or the United States Government.

Image credit: Shutterstock.com

Prev

Practicing medicine in a divided country

March 25, 2019 Kevin 8
…
Next

Reminding ourselves why we practice medicine

March 25, 2019 Kevin 0
…

Tagged as: Psychiatry

Post navigation

< Previous Post
Practicing medicine in a divided country
Next Post >
Reminding ourselves why we practice medicine

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Shaili Jain, MD

  • When the doctor becomes the victim

    Shaili Jain, MD
  • What #MeToo must learn from the science of sexual harassment

    Shaili Jain, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Integrating psychiatric care into primary care: The VA example

    Shaili Jain, MD

Related Posts

  • Stop stigmatizing medication-assisted treatment

    Brandon Jacobi
  • Physicians are at the frontline of depression

    Michele Luckenbaugh
  • Surviving medical school with depression

    Anonymous
  • My depression won’t defeat me

    Ronna Edelstein
  • Treating the patient’s body is not synonymous with treating the patient

    Steven Zhang, MD
  • How this student took care of his severe depression in medical school

    Anonymous

More in Meds

  • Why retail pharmacies are the future of diverse clinical trials

    Shelli Pavone
  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The hidden bias in how we treat chronic pain

    Richard A. Lawhern, PhD
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • Most Popular

  • Past Week

    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
    • Key strategies for smooth EHR transitions in health care

      Sandra Johnson | Tech
    • 2 hours to decide my future: How the SOAP residency match traps future doctors

      Nicolette V. S. Sewall, MD, MPH | Education
    • Reassessing the impact of CDC’s opioid guidelines on chronic pain care [PODCAST]

      The Podcast by KevinMD | Podcast
    • When the diagnosis is personal: What my mother’s Alzheimer’s taught me about healing

      Pearl Jones, MD | Conditions
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • “Think twice, heal once”: Why medical decision-making needs a second opinion from your slower brain (and AI)

      Harvey Castro, MD, MBA | Tech
  • Recent Posts

    • Why some doctors age gracefully—and others grow bitter

      Patrick Hudson, MD | Physician
    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • What the research really says about infrared saunas

      Khushali Jhaveri, MD | Conditions
    • How the cycle of rage is affecting physicians—and how to break free

      Alexandra M.P. Brito, MD and Jennifer L. Hartwell, MD | Conditions
    • Why ADHD in adults is often missed—and why it matters [PODCAST]

      The Podcast by KevinMD | Podcast
    • Dedicated hypermobility clinics can transform patient care

      Katharina Schwan, MPH | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
    • Key strategies for smooth EHR transitions in health care

      Sandra Johnson | Tech
    • 2 hours to decide my future: How the SOAP residency match traps future doctors

      Nicolette V. S. Sewall, MD, MPH | Education
    • Reassessing the impact of CDC’s opioid guidelines on chronic pain care [PODCAST]

      The Podcast by KevinMD | Podcast
    • When the diagnosis is personal: What my mother’s Alzheimer’s taught me about healing

      Pearl Jones, MD | Conditions
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • “Think twice, heal once”: Why medical decision-making needs a second opinion from your slower brain (and AI)

      Harvey Castro, MD, MBA | Tech
  • Recent Posts

    • Why some doctors age gracefully—and others grow bitter

      Patrick Hudson, MD | Physician
    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • What the research really says about infrared saunas

      Khushali Jhaveri, MD | Conditions
    • How the cycle of rage is affecting physicians—and how to break free

      Alexandra M.P. Brito, MD and Jennifer L. Hartwell, MD | Conditions
    • Why ADHD in adults is often missed—and why it matters [PODCAST]

      The Podcast by KevinMD | Podcast
    • Dedicated hypermobility clinics can transform patient care

      Katharina Schwan, MPH | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Treating depression with ketamine: We need incremental treatment for depression
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...